Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Notice is hereby given ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that its Board of Directors will meet on Friday, 30th May 2025. The Board will consider and approve the audited financial results (standalone and consolidated) for the fourth quarter and full financial year ended 31st March 2025. Additionally, the Board will consider and recommend a final dividend on the paid-up equity shares for FY 2024-25. The trading window for dealing in company securities has been closed until 48 hours after the financial results are declared, in line with insider trading regulations.
This is a routine pre-announcement ahead of the FY25 annual results and possible dividend declaration. No immediate impact on shareholders, but the upcoming results and dividend decision on 30th May will be the next significant catalyst for the stock.